Kestra Medical Technologies is Therapeutic Devices in United States that focus on cardioverter defibrillator business. Founded in 2014. They cover business area such as manufacturer, external and internal cardiac medical device, prove device therapy, quality and technical performance, sincere regard, patient comfort, dignity, care, vital information, life.
2014
( 10 years old in 2024 )
Cardioverter Defibrillator
-
3933 Lake Washington Boulevard North East
Suite 200
Kirkland, WA 98033
United States
Private
manufacturerexternal and internal cardiac medical deviceprove device therapyquality and technical performancesincere regardpatient comfortdignitycarevital informationlife
* We use standard office opening hours in near Kestra Medical Technologies's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Kestra Medical Technologies is Therapeutic Devices business from United States that founded in 2014 (10 years old in 2024), Kestra Medical Technologies business is focusing on Cardioverter Defibrillator.
Kestra Medical Technologies headquarter office and corporate office address is located in 3933 Lake Washington Boulevard North East Suite 200 Kirkland, WA 98033 United States.
Kestra Medical Technologies was founded in United States.
In 2024, Kestra Medical Technologies is currently focus on cardioverter defibrillator sector.
Above is snippet of Google Trends for "cardioverter defibrillator" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Kestra Medical Technologies, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
